We have observed
16 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after September 23, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
METHODS FOR TREATING BALDNESS AND PROMOTING HAIR GROWTH
RATIONAL DESIGN OF COMPONENTS OF THE OLIGO-SACCHARYLTRANSFERASE-CATALYSED ASPARAGINE-LINKED GLYCOSYLATION
LOW SODIUM MARGARINE SPREAD ENRICHED WITH PROBIOTICS
TREATMENT OF DISEASE WITH POLY-N-ACETY GLUCOSAMINE NANOFIBERS
Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using said compositions
Multiplex detection of nucleic acids
COMPOSITIONS AND METHODS FOR ACCURATELY IDENTIFYING MUTATIONS
Tumor suppression using placental stem cells
MICROORGANISMS AND METHODS FOR THE PRODUCTION OF 1.4- CYCLOHEXANEDIMETHANOL
TREATMENT OF SPINAL CORD INJURY AND TRAUMATIC BRAIN INJURY USING AMNION DERIVED ADHERENT CELLS
ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 158P1D7 PROTEINS
Use of tam receptor inhibitors as immunoenhancers and tam activators as immunosuppressors
Use of tam receptor inhibitors as antimicrobials
ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO CD37 PROTEINS
TREATMENT OF IMMUNE-RELATED DISEASES AND DISORDERS USING AMNION DERIVED ADHERENT CELLS
DERIVATIVES OF DOLAPROINE-DOLAISOLEUINE PEPTIDES